MRM-3379

· Mirum Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRM-3379, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) [Phase 2]